Abu-Shakra M, Buskila D, Shoenfeld Y (2003) Osteonecrosis in patients with buy R428 SLE. Clin Rev Allergy Immunol 25(1):13–24CrossRefPubMed 6. Mok CC, Lau CS, Wong RW (1998) Risk factors for avascular bone necrosis in systemic lupus erythematosus. Br J Rheumatol 37(8):895–900CrossRefPubMed 7. Calvo-Alén J, McGwin G, Toloza S, Fernández M, Roseman JM, Bastian HM, Cepeda EJ, González EB, Baethge BA, Fessler BJ, Vilá LM, Reveille JD, Alarcón GS, LUMINA Study Group (2006) Systemic
lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case–control study. Ann Rheum Dis 65(6):785–90CrossRefPubMed 8. Etminan M, Aminzadeh K, Matthew IR, Brophy JM (2008) Use of oral bisphosphonates and the risk of aseptic osteonecrosis:
a nested case–control study. J Rheumatol 35(4):691–5PubMed 9. van Staa TP, Cooper C, Leufkens HG, Bishop N (2003) Children and the risk of fractures caused by oral corticosteroids. J Bone Miner Res Adriamycin cell line 18(5):913–8CrossRefPubMed 10. van Staa TP, Abenhaim L (1994) The quality of information recorded on a UK database of primary care records: a study of hospitalization due to hypoglycemia and other conditions. Pharmacoepidemiol Drug Saf 3(1):15–21CrossRef 11. van Staa TP, Abenhaim L, Cooper C, Zhang B, Leufkens HG (2000) The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacoepidemiol
Drug Saf 9(5):359–66CrossRefPubMed 12. Wurst KE, Ephross SA, Loehr J, Clark DW, Guess HA (2007) The Glycogen branching enzyme utility of the general practice research database to examine selected congenital heart defects: a validation study. Pharmacoepidemiol Drug Saf 16(8):867–77CrossRefPubMed 13. Thomas SL, Edwards CJ, Smeeth L, Cooper C, Hall AJ (2008) How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the general practice research database. Arthritis Rheum 59(9):1314–21CrossRefPubMed 14. Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL (2007) Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 16(4):393–401CrossRefPubMed 15. Fink JC, Leisenring WM, Sullivan KM, Sherrard DJ, Weiss NS (1998) Avascular necrosis following bone marrow transplantation: a case–control study. Bone 22(1):67–71CrossRefPubMed 16. Rizzoli R, Burlet N, Cahall D, Delmas PD, Eriksen EF, Felsenberg D, Grbic J, Jontell M, Landesberg R, Laslop A, Wollenhaupt M, Papapoulos S, Sezer O, Sprafka M, Reginster JY (2008) Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis. Bone 42(5):841–7CrossRefPubMed 17. Woo SB, Hellstein JW, Kalmar JR (2006) Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144(10):753–61PubMed 18.